Loading
Latest filing published 01 Mar 2011 for MARTEK BIOSCIENCES CORP.
No signal scores available.
Barney B. Easterling Jr. discloses dealings in Martek Biosciences Corp to SEC (Form 4). In total, 9 filings cover trades dated from 19 March 2008 to 25 February 2011.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 1 March 2011, reports a share grant in Martek Biosciences Corp. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations